Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Natco
FDA Approves EVEROLIMUS — Natco Pharma Limited

# FDA Approves Generic Everolimus from Natco Pharma Natco Pharma Limited received FDA approval for its generic version of everolimus, an oral immunos...

AMNEAL
FDA Approves Unknown Drug — AMNEAL

Amneal Pharmaceuticals has received FDA approval for generic drug ANDA211374, a development that positions the company to capture market share amidst ...

Avenacy,
FDA Approves FOSAPREPITANT — Avenacy, LLC

Avenacy, LLC won FDA approval on Wednesday to sell the generic version of Fosaprepitant Dimeglumine, an IV anti-emetic used to prevent chemotherapy-in...

Alvogen
FDA Approves HYDROCODONE BITARTRATE — Alvogen Inc.

Alvogen Inc. secured FDA approval for ANDA 208269 to market generic Hydrocodone Bitartrate oral tablets, positioning the company to influence market p...

Sentynl
FDA Approves NULIBRY — Sentynl Therapeutics, Inc.

# FDA Approval Newswire **Sentynl Therapeutics Receives FDA Approval for NULIBRY (Fosdenopterin Hydrobromide), Expanding Treatment Options in Rare Di...

Amgen
FDA Approves REPATHA — Amgen USA Inc.

Amgen announced the FDA approval of its viocumab (Repatha) for a pediatric indication on February 26, promising to expand its lipid-lowering market sh...

Cipla
FDA Approves SUMATRIPTAN — Cipla USA Inc.

Cipla USA Inc announced Friday the approval of its Abbreviated New Drug Application (ANDA) for sumatriptan nasal spray, a generic version of the brand...

Slate
FDA Approves MYCOPHENOLIC ACID — Slate Run Pharmaceuticals, LLC

Slate Run Pharmaceuticals, LLC announced the February 2021 approval of its ANDA for mycophenolic acid oral tablets, a biosimilar to the original immun...

Bostal
FDA Approves FENOFIBRATE — Bostal LLC

The FDA has granted approval to Bostal LLC for the ANDA/Fenofibrate application (ANDA208476), marking the arrival of a generic version of fenofibrate....

Dr.
FDA Approves VIGABATRIN — Dr. Reddys Laboratories Inc.,

# FDA Approves Dr. Reddy's Laboratories Vigabatrin Generic, Expanding Market Competition Dr. Reddy's Laboratories Inc. has received FDA approval for ...

Eugia
FDA Approves FOSAPREPITANT DIMEGLUMINE — Eugia US LLC

The FDA has granted tentative approval to fosaprepitant dimeglumine, an intravenous antiemetic, enabling Eugia US LLC to enter the market pending fina...

Unichem
FDA Approves CELECOXIB — Unichem Pharmaceuticals (USA), Inc.

Unichem Pharmaceuticals (USA), Inc. received FDA approval for its oral Celecoxib ANDA on January 12, 2021, adding a generic entry to the cardiovascula...

Ascend
FDA Approves FINGOLIMOD — Ascend Laboratories, LLC

Ascend Laboratories, LLC received FDA approval Tuesday for the generic version of Fingolimod Hydrochloride (Gilenya), potentially intensifying generic...

AMGEN
FDA Approves Unknown Drug — AMGEN INC

Amgen Inc. has received regulatory approval for [Substance Name], a pivotal development that is expected to bolster the company's balance sheet and fo...

Sigmapharm
FDA Approves ASENAPINE — Sigmapharm Laboratories, LLC

Sigmapharm Laboratories secured FDA approval for its generic, sublingual Asenapine tablets, a development expected to increase generic market penetrat...

Dr.
FDA Approves CAPECITABINE — Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited received FDA approval for its generic capecitabine, an oral chemotherapy agent, strengthening its position in the U.S...

Ingenus
FDA Approves SCOPOLAMINE — Ingenus Pharmaceuticals, LLC

# FDA Approves Ingenus Pharmaceuticals' Generic Scopolamine Transdermal Patch Ingenus Pharmaceuticals, LLC has received FDA approval for its generic ...

ACCORD
FDA Approves Unknown Drug — ACCORD HLTHCARE

# FDA Approves Generic Drug Application for Accord Healthcare Accord Healthcare received FDA approval for ANDA 214425 on November 13, 2020, expanding...

Ascend
FDA Approves TACROLIMUS — Ascend Laboratories, LLC

Ascend Laboratories, LLC has announced the FDA approval of its tacrolimus ANDA, entering the competitive oral tacrolimus market with a potential impac...

Aurobindo
FDA Approves POMALIDOMIDE — Aurobindo Pharma Limited

# FDA Approves Generic Pomalidomide; Aurobindo Pharma Enters Multiple Myeloma Market Aurobindo Pharma Limited received FDA approval for its generic p...